NCT07181343 - A Drug-Drug Interaction Study Between HS-10374 Tablets and Drospirenone and Ethinyl Estradiol Tablets(Yasmin®) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 28, 2025

Primary Completion Date

June 17, 2025

Study Completion Date

August 19, 2025

Conditions

Psoriasis (PsO)

Interventions

DRUG

HS-10374 tablets

From Day 8 to Day 19, participants will orally take HS-10374 Tablets 12 mg（6 mg×2） once daily under fasting conditions

DRUG

Drospirenone and Ethinyl Estradiol tablets

On Day 1 and Day 14, participants will orally take one tablet of Drospirenone and Ethinylestradiol Tablets under fasting conditions.

Trial Locations (1)

The Affiliated Hospital of Qingdao University, Qingdao

All Listed Sponsors

lead

Hansoh BioMedical R&D Company

INDUSTRY